Cancer Treatment Centers of America® (CTCA), Chicago has honored CTCA® Chicago nurse, Lauren Drysdale, BSN, RN, with the DAISY Award for Extraordinary Nurses in recognition for her commitment and patient-centered approach to care. The award is part...
Cancer Treatment Centers of America in Tulsa hosted its 23rd annual Celebrate Life event, honoring patients who have met their five-year survival mark. Honorees Roxanne Waling and Vonda Zimmerman shared their thoughts on what it means to them to...
In this article in Oncology Times, David Topolsky, MD, Hematologist-Oncologist and Medical Oncologist at Cancer Treatment Centers of America® Philadelphia, discusses various treatments for bladder cancer, "the fourth most common malignancy in men...
Pamela Crilley, DO, Chair, Department of Medical Oncology at Cancer Treatment Centers of America® (CTCA), was recently appointed to the Editorial Advisory Board for HemOnc Times, a new monthly supplement to Oncology Times, an independent clinical...
Patient Lourdes Carini discusses what women should know when it comes to ovarian cancer symptoms, and shares tips that Natalie Godbee, DO, Gynecologic Oncologist at Cancer Treatment Centers of America® in Phoenix, shared with her in the hopes that...
In this Morning Consult commentary, Dr. Neil Seeley, CTCA® Chief of Anesthesia and Dr. Nathan Neufeld, CTCA Chief of Pain Management, highlight several fundamental issues surrounding the opioid crisis that must change to prevent further opioid...
CTCA Tulsa hosted a Prostate Pep Talk event to promote its partnership with the NFL Alumni (NFLA), Lab Corp, and Health Testing Centers to raise awareness of prostate cancer and the benefits of early screening.
In this article from SheKnows.com, Julian Schink, MD, Chief, CTCA Division of Gynecologic Oncology, discusses lifestyle changes that may reduce the risk for ovarian cancer.
In this Insider article about ovarian cancer, Julian Schink, MD, Chief, CTCA Division of Gynecologic Oncology, examines potential ovarian cancer symptoms that are non-specific (attributed to other issues).
Alan Tan, MD, Clinical Research Medical Director & Medical Oncologist and Hematologist, Cancer Treatment Centers of America® (CTCA), Phoenix discusses how talimogene laherparepvec (T-VEC) uses a genetically modified herpes virus to treat melanoma...
Cancer Treatment Centers of America® (CTCA) is now City of Hope®, a national, integrated cancer research and treatment system, united to expand patient access to personalized comprehensive cancer care across the United States. Learn what that means for you.